Apollo Therapeutics Ltd

This is an early safety study testing a new vaccine designed to protect against rhinovirus, a main cause of the common cold. Researchers will give the vaccine or a placebo to 144 healthy adults in Australia to check for side effects and see if it triggers an immune response. The …

This early-stage study is testing a new drug called APL-4098 to see if it's safe and effective for adults with advanced forms of blood cancer that have returned or stopped responding to other treatments. Researchers will give APL-4098 alone and in combination with two standard ca…

This early-stage study is testing a new drug called APL-5125 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can shrink tumors, especially in colorectal canc…

This study is testing whether APL-9796 injections are safe and might help control pulmonary hypertension, a serious condition where blood pressure in the lungs is dangerously high. The trial will involve 48 adults who already have a special heart sensor implanted to monitor their…